News | Nuclear Imaging | June 15, 2017

New Expert Consensus Outlines Strategies to Improve Myocardial Perfusion Imaging in Women

cardiac nuclear myocardial perfusion imaging (MIP) exam guidelines for women

June 15, 2017 — The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evidence-based treatment of stress myocardial perfusion imaging (MPI) in women. The consensus statement, “Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-art evidence and clinical recommendations,”[1] is intended to guide appropriate use of nuclear cardiology in the evaluation of women presenting with symptoms consistent with stable ischemic heart disease (SIHD).

Read the new consensus document

The consensus statement, features recommendations for:
• Using cardiovascular imaging as a gatekeeper to quality testing and treatment of at-risk women
• Selecting appropriate women for testing
• Implementing radiation-dose-reduction strategies in women
• Leveraging technology to probe relevant female biology
• Investing in cardiovascular imaging for research on women’s care and outcomes

“The document is an important first step to implementing a ‘precision medicine’ approach to patient care,” says Viviany R. Taqueti, M.D., MPH, who led the writing group. “The incorporation of sex-specific and evidence-based guidance for diagnostic testing to determine risk status and management of symptomatic women with suspected ischemia is an important first step to implementing a 'precision medicine' approach to patient care.” 

The writers of the document assert in the statement that for women, the evidence base for SPECT and PET MPI is robust and supports accurate detection of obstructive cardiovascular artery disease (CAD), effective risk stratification, and hopefully more appropriate utilization of invasive procedures.

“This document should help to improve patterns of care and clinical outcomes for the large sector of women requiring stress imaging procedures,” said Leslee Shaw, Ph.D., another author on the document. (Watch a video interview with Shaw on the future of cardiac CT imaging.)

Watch the VIDEO "Trends in Nuclear Cardiology Imaging," an interview with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), on advancements in nuclear imaging and some of the issues facing the subspecialty.

 

Reference:

1. Viviany R. Taqueti, Sharmila Dorbala, David Wolinsky. “Myocardial perfusion imaging in women for the evaluation of stable ischemic heart disease—state-of-the-evidence and clinical recommendations.” Journal of Nuclear Cardiology. doi:10.1007/s12350-017-0926-8. Published online June 5, 2017.  Accessed June 15, 2017.
Received May 15, 2017; accepted May 15, 2017

 

 

Read the article "Recent Advances in Cardiac Nuclear Imaging Technology." 

Watch the VIDEO "PET vs. SPECT in Nuclear Cardiology and Recent Advances in Technology." An interview with Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and president-elect of the American Society of Nuclear Cardiology (ASNC), explained advances in PET and SPECT imaging. 

Watch the VIDEO "Trends in Nuclear Cardiology Imaging." A discussion with David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty. 


Related Content

News | Cardiac Imaging

Dec. 1, 2025 — Cleerly, a provider of AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025 ...

Home December 02, 2025
Home
News | Cardiac Imaging

Nov. 30, 2025 — KA Imaging Technology has announced that its Reveal 35C detector with SpectralDR technology will be ...

Home December 01, 2025
Home
News | Cardiac Imaging

Nov. 13, 2025 — Esaote has announced a new strategic partnership with Schiller Americas. This collaboration strengthens ...

Home November 14, 2025
Home
News | Cardiac Imaging

Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform ...

Home October 02, 2025
Home
News | Cardiac Imaging

Sept. 22, 2025 — Heartflow, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen ...

Home September 23, 2025
Home
News | Cardiac Imaging

Aug. 13, 2025 — BioCardia, Inc., a provider of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home August 15, 2025
Home
News | Cardiac Imaging

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Home July 28, 2025
Home
News | Cardiac Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Home July 25, 2025
Home
News | Cardiac Imaging

July 17, 2025— Heartflow, Inc. recently announced new data for its AI-enabled Heartflow Plaque Analysis, including final ...

Home July 17, 2025
Home
News | Cardiac Imaging

July 15, 2025 – Cleerly has announced that EviCore, a leading radiology benefit manager providing coverage guidelines to ...

Home July 16, 2025
Home
Subscribe Now